iRhythm director receives 1,573-share equity grant

YOOR BRIAN B reported acquisition or exercise transactions in this Form 4 filing. iRhythm Holdings, Inc. director Brian B. Yoor reported receiving an equity award of 1,573 shares of common stock as a grant, with no cash paid per share.

Rhea-AI Filing Summary

YOOR BRIAN B reported acquisition or exercise transactions in this Form 4 filing.

iRhythm Holdings, Inc. director Brian B. Yoor reported receiving an equity award of 1,573 shares of common stock as a grant, with no cash paid per share. After this award, he holds 7,171 shares directly. The award consists of restricted stock units, each convertible into one share of common stock, vesting on the earlier of one year after grant or the company’s next annual meeting.

Insider Trade Summary

Grant/Award: 1,573 shares

Grant/Award 1 txn

Insider YOOR BRIAN B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,573	$0.00	$0.00

Holdings After Transaction: Common Stock — 7,171 shares (Direct)

Footnotes (1)

1. F1. These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Key Figures

Equity award size: 1,573 shares Price per share: $0.0000 per share Post-transaction holdings: 7,171 shares +1 more

4 metrics

Equity award size 1,573 shares Grant of common stock as reported on Form 4

Price per share $0.0000 per share Reported grant price for awarded shares

Post-transaction holdings 7,171 shares Total common stock held directly after grant

Vesting condition Earlier of 1 year or next annual meeting RSU vesting schedule from footnote

Key Terms

restricted stock units, RSUs, annual meeting

3 terms

restricted stock units financial

"These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSUs financial

"These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock."

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

annual meeting financial

"The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting."

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did iRhythm (IRTC) director Brian B. Yoor report?

Brian B. Yoor reported receiving a grant of 1,573 shares of iRhythm common stock as an equity award. The grant is in the form of restricted stock units that convert into shares upon vesting, rather than an open-market purchase or sale.

How many iRhythm (IRTC) shares does Brian B. Yoor hold after this Form 4?

Following the reported grant, Brian B. Yoor holds 7,171 shares of iRhythm common stock directly. This total includes the 1,573-share equity award disclosed in the filing and reflects his position after the transaction was recorded.

Was cash paid for the iRhythm (IRTC) shares granted to Brian B. Yoor?

No cash was paid per share for this transaction; the price per share is reported as 0.0000. The filing characterizes the transaction as a grant or award, indicating compensation-related equity rather than an open-market trade.

What are the vesting terms of the iRhythm (IRTC) restricted stock units granted?

The restricted stock units vest on the earlier of one year after the grant date or the date of iRhythm’s next annual meeting. Upon vesting, each unit entitles the holder to receive one share of iRhythm common stock, subject to the award terms.

Does the iRhythm (IRTC) Form 4 show a buy or sell by Brian B. Yoor?

The Form 4 reports an acquisition through a grant or award, not an open-market buy or sell. The transaction code is “A,” describing a grant, award, or other acquisition of 1,573 shares as equity compensation.

What type of security was granted in the iRhythm (IRTC) Form 4 filing?

The filing describes the award as restricted stock units, each representing a contingent right to receive one share of iRhythm common stock. These RSUs convert into shares once the stated vesting conditions are satisfied, aligning the director’s compensation with company equity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/29/2026 - 04:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

YOOR BRIAN B

(Last) (First) (Middle)

C/O IRHYTHM HOLDINGS, INC.

699 8TH ST #600

(Street)

SAN FRANCISCO CALIFORNIA 94103

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
iRhythm Holdings, Inc. [ IRTC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/27/2026		A		1,573(1)	A	$0	7,171	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Remarks:

(1) On January 12, 2026, iRhythm Technologies, Inc. (iRhythm Tech) and iRhythm Holdings, Inc. (Issuer) effectuated a holding company reorganization pursuant to which the Issuer became the successor issuer to iRhythm Tech pursuant to Rule 12g-3(a) of the Securities Exchange Act of 1934, as amended. On such date, all outstanding shares and equity awards of iRhythm Tech automatically converted into securities of the Issuer on a one for one basis, with no change to the proportionate interests of security holders. (2) Exhibit 24 - Power of Attorney

	/s/ Marc Rosenbaum, attorney-in-fact	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)